Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2023.04.04
大地妈妈：关于子公司签订分销供应协议的公告
2023.03.30
大地妈妈：年度股东大会通知
2023.03.30
大地妈妈：内部控制自我评价报告
2023.03.30
大地妈妈：内部控制审计报告
2023.03.30
大地妈妈：商誉减值报告
2023.03.30
大地妈妈：监事会决议公告
2023.03.30
大地妈妈：年度关联方资金占用专项审计报告
2023.03.30
大地妈妈：关于开展以套期保值为目的的外汇衍生品交易的公告
2023.03.30
大地妈妈：关于增加经营范围及修订《公司章程》的公告
2023.03.30
大地妈妈：独立董事提名人声明（黄鹏）
第一页
上一页
12
13
14
15
16
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
